All locations

See a listing of all our Children’s Hospital Colorado locations including inpatient, outpatient, therapy, surgery facilities and more.

Locations near you

See all locations

Jean Mulcahy Levy, MD

Provider's Specialties

Hematology/Oncology - Pediatric
Pediatrics

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Read reviews

Center for Cancer and Blood Disorders

(720)777-6772

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

My care philosophy

I strive to provide the best care for my patients. I believe in treating the patient and family as a whole.

Get to know Jean Mulcahy Levy, MD

Departments and Programs

Conditions Treated

Brain Tumors
Leukemia
Pediatric Cancer

Languages spoken

English

Experience and background

My clinical interests focus on the care of children with tumors involving the brain and spinal cord, using a combination of therapies and coordinating services including surgery, radiation, and chemotherapy to improve outcomes for these patients.

Undergraduate 1998

University of Portland (OR)

Medical Education 2003

Oregon Health & Science University School of Medicine

Internship 2004

University of Arizona Program

Residency 2006

University of Arizona Program

Fellowship 2012

University of Colorado (Children's Hospital Colorado) Program

Website: http://www.ncbi.nlm.nih.gov/pubmed?term="Levy JM"[Author]

For Patients:
My research interests focus on autophagy, a multi-step process that cancer can use to survive. It is possible to block this survival mechanism and hopefully make cancer easier to kill with other treatments like radiation and chemotherapy. My research has three goals to improve survival of kids with brain tumors. First, find which step of the process should be blocked to kill the most tumor cells. Second, to find which brain tumors depend most on autophagy to survive. And finally, to determine if a specific genetic mutation found in some pediatric brain tumors can identify patients who will most benefit from autophagy directed treatments.

For Referring Providers:
My laboratory research focus is the study of autophagy, a multi-step cellular catabolic process that turns over long-lived proteins and organelles and contributes to cell and organism survival during nutrient deprivation and other stresses. Autophagy has been shown to be important in the development of cancer and is a promising target for manipulation to improve cancer treatment and survival. My goal is to determine how to utilize autophagy to improve therapy for patients with malignant central nervous system (CNS) tumors. I also have a translational research interest in using the power of laboratory findings to identify patients at higher risk of adverse neurocognitive outcomes due to the negative effects of radiation and chemotherapy.